The time required for in-clinic drug administration can substantially affect breast cancer patients' quality of life. Subcutaneous (SC) drug administration, as opposed to intravenous (IV), may reduce ...
A new investigational drug called gedatolisib can help keep cancer from returning for longer for certain patients with HR+, ...
Subcutaneous administration of trastuzumab/pertuzumab could save breast cancer patients and healthcare providers substantial amounts of time compared with intravenous ...
Medicare covers intravenous (IV) infusion therapy when a doctor prescribes it as medically necessary. Original Medicare Part A typically covers the costs if you have an IV infusion during an inpatient ...
Jocelyn Mueller, a patient with HER2-postive breast cancer, explains the recovery process after surgery and the impact that the availability sub-cutaneous HER2-targeting therapy has had on her breast ...
Tecovirimat 200mg/vial; soln for IV infusion after dilution; contains hydroxypropyl-β-cyclodextrin. Store Tpoxx injection in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. The diluted ...
Original Medicare provides coverage for IV infusion therapy when a doctor determines it to be medically necessary, both in a clinic setting and at home. Medicare Advantage (Part C) plans need to offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results